Science Explorer Back to mapMap
Discussion
Researcher · Region Jönköpings län · Sweden

Mats Bojestig

Mats Bojestig publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology, on topics such as Chronic Kidney Disease and Diabetes, Acute Myocardial Infarction Research and Diabetes Management and Research.

OpenAlex
World rank
#1,578,156
of 7,710,434 ranked researchers
Rank in Sweden
#20,420
of 71,437
Works
23
Citations
1.4k
Citations per work
60.2
h-index
15
i10-index 17Top 35% in Endocrinology, Diabetes and Metabolism
Mats Bojestig

What does Mats Bojestig research?

Mats Bojestig's work is mostly in Medicine (65%), Health Professions (10%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 17 works · 75.0% of their workMedicine: 15 works · 64.7% of their workEndocrinology, Diabetes and Metabolism: 5 works · 23.5% of their workCardiology and Cardiovascular Medicine: 5 works · 22.1% of their workNephrology: 3 works · 14.7% of their workOphthalmology: 1 works · 4.4% of their workHealth Professions: 2 works · 10.3% of their workGeneral Health Professions: 2 works · 10.3% of their workEverything else: 4 works · 19.1% of their workLife Sciences: 1 works · 5.9% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 5.9% of their workGenetics: 1 works · 5.9% of their workTHEIR WORKMats Bojestig23works
Life Sciences6%Health Sciences75%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1564.7%
    2. Health Professions210.3%
  2. Everything else419.1%
    1. Biochemistry, Genetics and Molecular Biology15.9%
  1. 1Endocrinology, Diabetes and Metabolism24% of their works
  2. 2Cardiology and Cardiovascular Medicine22% of their works
  3. 3Nephrology15% of their works
  4. 4General Health Professions10% of their works
  5. 5Genetics6% of their works
  6. 6Ophthalmology4% of their works

Research topics

Which keywords describe Mats Bojestig's research?

The keywords of their largest research topics: Cardiovascular Disease, Global Burden, Insulin Therapy, Myocardial Infarction, Type 1 Diabetes, Chronic Kidney Disease, Glomerular Filtration Rate and Clinical Guidelines.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Cardiovascular Disease224 topics
  2. Global Burden112 topics
  3. Insulin Therapy92 topics
  4. Myocardial Infarction92 topics
  5. Type 1 Diabetes92 topics
  6. Chronic Kidney Disease81 topic
  7. Glomerular Filtration Rate81 topic
  8. Clinical Guidelines72 topics
  9. Acute Coronary Syndromes61 topic
  10. ST-Segment Elevation61 topic
  11. Diabetes51 topic
  12. Hypoglycemia51 topic
  13. Autoimmunity41 topic
  14. Cardiovascular Outcomes41 topic
  15. Genetics41 topic
  16. Type 2 Diabetes41 topic
  17. Blood Pressure31 topic
  18. Cardiac Rehabilitation31 topic
  19. Depression31 topic
  20. Hypertension31 topic
  21. Macular Degeneration31 topic
  22. Retinal Pigment Epithelium31 topic

Where does Mats Bojestig work?

Mats Bojestig's main affiliation in the publication record is Region Jönköpings län, Sweden.

How many publications and citations does Mats Bojestig have?

OpenAlex counts 23 works and 1,385 citations for Mats Bojestig, an h-index of 15, ranking #1,578,156 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mats Bojestig. Posts are plain text and can be reported.